Viewing Study NCT00021034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-27 @ 4:57 AM
Study NCT ID: NCT00021034
Status: COMPLETED
Last Update Posted: 2013-06-18
First Post: 2001-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module